Tekla Capital Management LLC - CRISPR THERAPEUTICS AG ownership

CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 310 filers reported holding CRISPR THERAPEUTICS AG in Q3 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.3%.

Quarter-by-quarter ownership
Tekla Capital Management LLC ownership history of CRISPR THERAPEUTICS AG
ValueSharesWeighting
Q2 2023$1,267,136
-49.1%
22,571
-59.0%
0.05%
-47.4%
Q1 2023$2,491,268
+11.3%
55,0800.0%0.10%
+11.8%
Q4 2022$2,239,002
-37.8%
55,0800.0%0.08%
-42.2%
Q3 2022$3,599,000
+7.5%
55,0800.0%0.15%
+11.4%
Q2 2022$3,347,000
-3.2%
55,0800.0%0.13%
+9.1%
Q1 2022$3,457,000
-17.2%
55,0800.0%0.12%
-9.7%
Q4 2021$4,174,000
-77.0%
55,080
-66.1%
0.13%
-77.1%
Q3 2021$18,170,000
-30.9%
162,3370.0%0.58%
-31.5%
Q2 2021$26,281,000
+42.9%
162,337
+7.5%
0.85%
+34.9%
Q1 2021$18,394,000
+57.6%
150,958
+98.1%
0.63%
+54.4%
Q4 2020$11,670,000
+83.1%
76,2220.0%0.41%
+71.5%
Q3 2020$6,375,000
+13.8%
76,2220.0%0.24%
+12.2%
Q2 2020$5,602,000
+73.3%
76,2220.0%0.21%
+45.9%
Q1 2020$3,233,000
-30.4%
76,2220.0%0.15%
-17.0%
Q4 2019$4,642,000
+11.7%
76,222
-24.8%
0.18%
-2.8%
Q3 2019$4,154,000
-50.5%
101,336
-43.2%
0.18%
-47.2%
Q2 2019$8,400,000
+31.8%
178,3480.0%0.34%
+32.4%
Q1 2019$6,371,000
+25.0%
178,3480.0%0.26%
+18.8%
Q4 2018$5,095,000
-35.6%
178,3480.0%0.22%
-24.0%
Q3 2018$7,910,000
-24.5%
178,3480.0%0.29%
-27.9%
Q2 2018$10,480,000
+62.4%
178,348
+26.3%
0.40%
+58.6%
Q1 2018$6,454,000141,1910.25%
Other shareholders
CRISPR THERAPEUTICS AG shareholders Q3 2020
NameSharesValueWeighting ↓
Versant Venture Management, LLC 498,558$31,294,00031.24%
NEA Management Company, LLC 1,590,002$365,593,00010.56%
Ariose Capital Management Ltd 37,900$2,379,0009.30%
ARK Investment Management 9,404,071$590,294,0002.46%
NIA IMPACT ADVISORS, LLC 80,082$5,027,0002.44%
Nikko Asset Management Americas, Inc. 4,619,747$291,044,0002.14%
PLUSTICK MANAGEMENT LLC 50,000$3,139,0001.98%
Integral Health Asset Management, LLC 120,000$7,532,0001.96%
Valiant Capital Management, L.P. 240,683$15,108,0001.73%
Deuterium Capital Management, LLC 18,000$1,130,0001.45%
View complete list of CRISPR THERAPEUTICS AG shareholders